Jiang Liuyan, Abati Andrea D, Wilson Wyndham, Stetler-Stevenson Maryalice, Yuan Constance
Laboratory of Pathology, Hematopathology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Int J Clin Exp Pathol. 2009 Oct 15;3(1):110-6.
Hepatosplenic (gammadelta) T-cell lymphoma (HSTCL) is an uncommon T-cell lymphoma with an aggressive clinical course and poor prognosis. Bone marrow and peripheral blood are frequently involved, with central nervous system involvement less common. We describe a case of a 31-year old man diagnosed with a gammadelta HSTCL in 2003, successfully treated with chemotherapy and allogeneic stem cell transplantation, and followed from 2003 to present. Four-color flow cytometry (FC) was performed on a BD FACSCalibur and data analyzed with CellQuest Pro and FCS Express software. For cerebrospinal fluid (CSF), all cells were acquired due to limited material. Cytological correlation was available on all specimens. Molecular studies for T-cell gene rearrangement were non-contributory. By FC, the diagnostic HSTCL immunophenotype was CD3 (+), CD7 (+), CD2 (+), CD5 (-), CD4 (-), CD8 (-), TCR gammadelta (+). Subsequent CSF FC analysis revealed a distinct population of gammadelta T-cells in all specimens, ranging from <1% to 13% of lymphocytes. Consistently, the gammadelta T-cells exhibited a different immunophenotypic profile from the reported diagnostic immunophenotype; they expressed CD5, and exhibited a heterogeneous pattern of CD8 expression. Comparison to in-house cases from patients with hairy cell leukemia and concomitant increases in non-neoplastic gammadelta T-cells was performed. The persistent gammadelta T-cells from the CSF of the patient with HSTCL were immunophenotypically consistent with non-neoplastic gammadelta T-cells. We describe an unusual case of persistent gammadelta T-cells in the CSF of a patient during 6 years of flow cytometric follow-up after treatment for gammadelta HSTCL. By cytology, non-neoplastic and malignant gammadelta T-cells are often difficult to distinguish. FC analysis helps to make this distinction, even with a limited panel. By FC, the gammadelta-T cells in the CSF of this patient are immunophenotypically consistent with non-neoplastic gammadelta T-cells. Remarkably, this finding is underscored by the patient's unusual clinical picture; he remains well and disease free.
肝脾(γδ)T细胞淋巴瘤(HSTCL)是一种罕见的T细胞淋巴瘤,临床病程侵袭性强,预后较差。骨髓和外周血常受累,中枢神经系统受累较少见。我们描述了一例31岁男性患者,2003年被诊断为γδ HSTCL,经化疗和异基因干细胞移植成功治疗,自2003年起随访至今。使用BD FACSCalibur进行四色流式细胞术(FC)检测,并使用CellQuest Pro和FCS Express软件分析数据。对于脑脊液(CSF),由于样本量有限,采集了所有细胞。所有标本均有细胞学相关性。T细胞基因重排的分子研究无贡献。通过FC检测,诊断HSTCL的免疫表型为CD3(+)、CD7(+)、CD2(+)、CD5(-)、CD4(-)、CD8(-)、TCRγδ(+)。随后的脑脊液FC分析显示,所有标本中均有一群独特的γδ T细胞,占淋巴细胞的比例从<1%到13%不等。一致的是,γδ T细胞表现出与报道的诊断免疫表型不同的免疫表型特征;它们表达CD5,并表现出CD8表达的异质性模式。与毛细胞白血病患者的内部病例进行了比较,并观察了非肿瘤性γδ T细胞的伴随增加情况。HSTCL患者脑脊液中持续存在的γδ T细胞在免疫表型上与非肿瘤性γδ T细胞一致。我们描述了一例在γδ HSTCL治疗后的6年流式细胞术随访期间,患者脑脊液中持续存在γδ T细胞的不寻常病例。通过细胞学检查,非肿瘤性和恶性γδ T细胞往往难以区分。FC分析有助于进行这种区分,即使使用有限的检测指标。通过FC检测,该患者脑脊液中的γδ T细胞在免疫表型上与非肿瘤性γδ T细胞一致。值得注意的是,患者不寻常的临床情况突出了这一发现;他一直状况良好且无疾病。